Yiwei Wang
- Biological Psychiatry top 10%
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms 4
- Developmental Neuroscience top 10%
-
- Intensive Care Unit Cognitive Disorders 3
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Metabolomics and Mass Spectrometry Studies 3
- Glycosylation and Glycoproteins Research 2
-
- Pharmacological Effects of Natural Compounds 3
- Berberine and alkaloids research 3
-
- Alzheimer's disease research and treatments 3
- Co-authors
- Roberta Dı́az BrintonHongquan DongYanning QianQin ZhouJie SunFei YinMengmeng XuShuofeng Zhang
- Journals
- Journal of Neuroinflammation (3 papers)Journal of Biomedical Nanotechnology (2 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yiwei Wang
39 papers receiving 754 citations
Peers
Comparison fields: 5 of 97
- Biological Psychiatry 50
- Neurology 139
- Developmental Neuroscience 64
- Critical Care and Intensive Care Medicine 66
- Aging 14
Countries citing papers authored by Yiwei Wang
This map shows the geographic impact of Yiwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiwei Wang more than expected).
Fields of papers citing papers by Yiwei Wang
This network shows the impact of papers produced by Yiwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiwei Wang. The network helps show where Yiwei Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yiwei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 13 | |
| 6 | 2022 | 7 | |
| 7 | 2021 | 7 | |
| 8 | 2021 | 22 | |
| 9 | 2020 | 28 | |
| 10 | 2020 | 16 | |
| 11 | 2020 | 26 | |
| 12 | 2018 | 37 | |
| 13 | 2018 | 115 | |
| 14 | 2017 | 70 | |
| 15 | 2015 | 5 | |
| 16 | [Pharmacokinetics and pharmacodynamics of huangqin tang in febrile rats]. | 2014 | 2 |
| 17 | 2014 | 14 | |
| 18 | [Construction and immunogenicity of recombinant bacteriophage T7 vaccine expressing M2e peptides of avian influenza virus]. | 2013 | 2 |
| 19 | [LC-MS quantification and pharmacokinetics of the multi-constituents of Huangqin Tang in rat plasma after different single oral doses]. | 2013 | 7 |
| 20 | Pharmacokinetics Study of Corydalis Extracts in Rat Plasma | 2011 | 3 |
About Yiwei Wang
Yiwei Wang is a scholar working on Biological Psychiatry, Critical Care and Intensive Care Medicine, Pharmacology, Aging and Behavioral Neuroscience, having authored 41 papers that have together received 760 indexed citations. Recurring topics across this work include Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Pharmacological Effects of Natural Compounds (3 papers), Intensive Care Unit Cognitive Disorders (3 papers), Berberine and alkaloids research (3 papers), Alzheimer's disease research and treatments (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Biological Psychiatry (50 citations), Neurology (139 citations), Developmental Neuroscience (64 citations), Critical Care and Intensive Care Medicine (66 citations) and Aging (14 citations). Yiwei Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Roberta Dı́az Brinton, Hongquan Dong, Yanning Qian, Qin Zhou, Jie Sun, Fei Yin, Mengmeng Xu, Yanning Qian, Shuofeng Zhang and Brian Chi‐Yan Cheng. Their work appears in journals such as Journal of Neuroinflammation, Journal of Biomedical Nanotechnology, PLoS ONE, Scientific Reports and International Orthopaedics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.